Wells Fargo
IDYA icon

Wells Fargo’s IDEAYA Biosciences IDYA Stock Holding History

Wells Fargo’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
297,848
+54,520
+22% +$1.67M ﹤0.01% 2112
2026
Q1 		$8.11M Sell
243,328
-12,816
-5% -$430K ﹤0.01% 2207
2025
Q4 		$8.85M Buy
256,144
+13,136
+5% +$419K ﹤0.01% 2153
2025
Q3 		$6.61M Buy
243,008
+25,874
+12% +$626K ﹤0.01% 2345
2025
Q2 		$4.56M Buy
217,134
+47,782
+28% +$917K ﹤0.01% 2551
2025
Q1 		$2.77M Buy
169,352
+18,833
+13% +$401K ﹤0.01% 2898
2024
Q4 		$3.87M Sell
150,519
-3,093
-2% -$87.6K ﹤0.01% 2642
2024
Q3 		$4.87M Buy
153,612
+4,388
+3% +$166K ﹤0.01% 2360
2024
Q2 		$5.24M Buy
149,224
+23,972
+19% +$949K ﹤0.01% 2210
2024
Q1 		$5.5M Buy
125,252
+108,031
+627% +$4.65M ﹤0.01% 2191
2023
Q4 		$613K Sell
17,221
-18,670
-52% -$557K ﹤0.01% 3728
2023
Q3 		$968K Sell
35,891
-7,272
-17% -$184K ﹤0.01% 3350
2023
Q2 		$1.01M Buy
43,163
+13,555
+46% +$279K ﹤0.01% 3467
2023
Q1 		$407K Buy
29,608
+29,091
+5,627% +$485K ﹤0.01% 3990
2022
Q4 		$9.39K Sell
517
-1,080
-68% -$18.2K ﹤0.01% 5575
2022
Q3 		$24K Buy
1,597
+197
+14% +$2.56K ﹤0.01% 5306
2022
Q2 		$19K Sell
1,400
-31,272
-96% -$348K ﹤0.01% 5480
2022
Q1 		$365K Sell
32,672
-9,034
-22% -$133K ﹤0.01% 4630
2021
Q4 		$986K Buy
41,706
+18,424
+79% +$428K ﹤0.01% 4117
2021
Q3 		$593K Sell
23,282
-1,933
-8% -$45.1K ﹤0.01% 4567
2021
Q2 		$529K Buy
25,215
+5,155
+26% +$106K ﹤0.01% 4587
2021
Q1 		$472K Sell
20,060
-16,903
-46% -$326K ﹤0.01% 4716
2020
Q4 		$517K Buy
36,963
+23,909
+183% +$324K ﹤0.01% 4491
2020
Q3 		$164K Buy
13,054
+6,338
+94% +$78.5K ﹤0.01% 5051
2020
Q2 		$95K Buy
6,716
+6,681
+19,089% +$52.6K ﹤0.01% 5245
2020
Q1 		$0 Buy
+35
New +$248 ﹤0.01% 6464

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Wells Fargo's IDYA Position: Q2 2026 in Review

Wells Fargo increased its IDEAYA Biosciences (IDYA) stake by 22% in Q2 2026, buying an estimated $1.67M and bringing the position to 297,848 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

Wells Fargo first reported a position in IDYA in Q1 2020 and has held it in 26 quarters since. 285 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Wells Fargo held 297,848 shares of IDEAYA Biosciences worth $11.1M as of Q2 2026.
  • Wells Fargo bought 54,520 IDEAYA Biosciences shares in Q2 2026, an estimated $1.67M.
  • IDEAYA Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2112 holding.
  • Wells Fargo first reported a position in IDEAYA Biosciences in Q1 2020 and has held it in 26 quarters since.
  • 285 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.